GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wellbeing Digital Sciences KONEF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2022

Revenue

C$6.4m

FY2018FY2022

Net income

−C$25.2m

FY2018FY2022

Free cash flow

−C$3,730

FY2018FY2022

Shareholders' equity

−C$229,260

FY2018FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018
RevenueC$6.4mC$1.1m———
Operating income−C$23.8m−C$7.7m−C$609,484C$5.4m−C$207,860
Net income−C$25.2m−C$31.9mC$1.1m−C$6.6m−C$207,860
Diluted earnings per share-0.19-0.270.02-0.23-0.00

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018
Total assetsC$17.2mC$21.9mC$4.9mC$3.7mC$1.5m
Cash and short-term investmentsC$315,196C$3.6mC$4.8mC$3.2mC$1.5m
Total liabilitiesC$17.4mC$14.0mC$77,429C$17,055C$27,987
DebtC$2.1mC$337,172C$70,244——
Shareholders' equity−C$229,260C$7.9mC$4.8mC$3.7mC$1.5m
Shares outstanding130m119m58m29m115m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018
Cash from operations−C$3,636−C$2.3m−C$589,792−C$637,836−C$152,266
Capital spending−C$94−C$1,988−C$1,988−C$1,988−C$1,439
Free cash flow−C$3,730−C$2.3m−C$591,780−C$639,824−C$153,705

Latest quarters

By quarter end

Jul 2022Apr 2022Jan 2022Oct 2021Jul 2021Apr 2021Jan 2021Oct 2020
RevenueC$1.2mC$1.6mC$1.7mC$2.0mC$818,819C$2,734—C$1,478
Operating income−C$3.7m−C$5.7m−C$6.4m−C$9.2m−C$3.5m−C$2.3m−C$150,961−C$435,539
Net income−C$4.1m−C$5.4m−C$6.5m−C$9.2m−C$19.6m−C$2.3m−C$721,821−C$438,527
Diluted earnings per share-0.03-0.04-0.05-0.08-0.16-0.02-0.01-0.01
Cash from operations———−C$2.0m————
Total assetsC$17.2mC$17.7mC$18.3mC$19.1mC$15.9mC$4.9mC$5.7mC$3.1m
Cash and short-term investmentsC$315,196C$298,125C$654,893C$1.1mC$2.6mC$4.7mC$5.6mC$3.0m
DebtC$2.1mC$1.8mC$1.9mC$431,298C$171,351C$12,086C$11,672C$22,560
Shareholders' equity−C$229,260C$935,873C$2.6mC$4.7mC$5.7mC$4.8mC$5.6mC$3.1m

Growth per year

Compound annual rate

3 years5 years10 years
Net income56.5%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-415.2%———
Net margin-754.3%———

Share price return

Finished calendar years

2025
Return0%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.